Ipca Laboratories Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Ipca Laboratories Ltd with 125 companies shown from the same industry classification, including Gland Pharma Ltd, Glaxosmithkline Pharmaceuticals Ltd, Ajanta Pharma Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Ipca Laboratories Ltd | 49,578 Cr. | 1,951 | 2,039/1,252 | 36.1 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Gland Pharma Ltd | 48,056 Cr. | 2,912 | 3,042/1,574 | 34.0 | 656 | 0.69 % | 17.4 % | 12.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 46,239 Cr. | 2,733 | 3,121/2,088 | 43.9 | 134 | 2.09 % | 61.4 % | 45.6 % | 10.0 |
| Ajanta Pharma Ltd | 43,546 Cr. | 3,486 | 3,797/2,380 | 38.4 | 362 | 0.92 % | 34.5 % | 27.1 % | 2.00 |
| Abbott India Ltd | 57,035 Cr. | 26,840 | 30,655/25,135 | 35.3 | 2,247 | 1.96 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 60,234 Cr. | 370 | 447/338 | 82.8 | 210 | 0.14 % | 3.61 % | 1.40 % | 5.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,603 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Alkem Laboratories Ltd | 61,847 Cr. | 5,192 | 5,934/5,051 | 27.2 | 1,156 | 1.02 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Life Sciences Ltd | 64,392 Cr. | 2,282 | 2,538/1,793 | 20.6 | 372 | 0.21 % | 39.8 % | 23.6 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 64,624 Cr. | 2,295 | 2,538/1,793 | 20.7 | 372 | 0.22 % | 39.8 % | 23.6 % | 1.00 |
| Wockhardt Ltd | 33,862 Cr. | 2,084 | 2,422/1,087 | 84.9 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| Neuland Laboratories Ltd | 28,077 Cr. | 21,875 | 24,235/11,500 | 56.4 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| Acutaas Chemicals Ltd | 26,170 Cr. | 3,196 | 3,740/1,374 | 67.8 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Granules India Ltd | 22,319 Cr. | 817 | 924/520 | 34.3 | 205 | 0.21 % | 15.5 % | 13.8 % | 1.00 |
| Shilpa Medicare Ltd | 20,177 Cr. | 1,031 | 1,096/260 | 71.0 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Caplin Point Laboratories Ltd | 19,790 Cr. | 2,604 | 2,991/1,500 | 29.7 | 443 | 0.31 % | 24.2 % | 20.9 % | 2.00 |
| Pfizer Ltd | 17,595 Cr. | 3,842 | 5,578/3,792 | 22.9 | 919 | 1.95 % | 24.1 % | 18.0 % | 10.0 |
| Cohance Lifesciences Ltd | 17,267 Cr. | 451 | 918/267 | 160 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| ERIS Lifesciences Ltd | 16,490 Cr. | 1,189 | 1,740/1,163 | 25.2 | 282 | 0.61 % | 14.1 % | 18.7 % | 1.00 |
| Alembic Pharmaceuticals Ltd | 16,344 Cr. | 831 | 998/635 | 21.9 | 289 | 1.44 % | 12.6 % | 13.4 % | 2.00 |
| Natco Pharma Ltd | 16,106 Cr. | 822 | 1,217/786 | 14.1 | 470 | 0.61 % | 17.4 % | 17.1 % | 2.00 |
| Jubilant Pharmova Ltd | 15,616 Cr. | 982 | 1,185/784 | 40.2 | 445 | 0.51 % | 8.99 % | 6.53 % | 1.00 |
| Marksans Pharma Ltd | 15,048 Cr. | 332 | 351/155 | 29.1 | 66.7 | 0.27 % | 18.8 % | 15.2 % | 1.00 |
| Astrazeneca Pharma India Ltd | 14,774 Cr. | 5,909 | 9,850/5,882 | 85.2 | 349 | 0.61 % | 29.3 % | 23.3 % | 2.00 |
| Concord Biotech Ltd | 14,375 Cr. | 1,374 | 1,648/987 | 50.6 | 193 | 0.55 % | 17.4 % | 12.6 % | 1.00 |
| Blue Jet Healthcare Ltd | 10,255 Cr. | 542 | 693/325 | 43.6 | 78.4 | 0.22 % | 26.1 % | 19.4 % | 2.00 |
| Procter & Gamble Health Ltd | 8,791 Cr. | 5,300 | 6,975/4,700 | 26.4 | 316 | 2.92 % | 83.9 % | 61.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 8,782 Cr. | 968 | 1,002/584 | 40.8 | 234 | 0.36 % | 10.7 % | 8.59 % | 5.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Suven Life Sciences Ltd | 8,711 Cr. | 308 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Morepen Laboratories Ltd | 7,414 Cr. | 135 | 138/33.0 | 63.2 | 22.8 | 0.15 % | 8.05 % | 5.33 % | 2.00 |
| Entero Healthcare Solutions Ltd | 7,315 Cr. | 1,681 | 1,920/944 | 56.7 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Lupin Ltd | 92,061 Cr. | 2,011 | 2,530/1,900 | 15.5 | 491 | 0.90 % | 29.9 % | 28.7 % | 2.00 |
| Bliss GVS Pharma Ltd | 7,063 Cr. | 665 | 745/118 | 51.3 | 113 | 0.23 % | 16.9 % | 11.8 % | 1.00 |
| Sanofi India Ltd | 6,978 Cr. | 3,024 | 4,898/3,000 | 20.4 | 359 | 2.48 % | 57.5 % | 43.0 % | 10.0 |
| IOL Chemicals & Pharmaceuticals Ltd | 6,036 Cr. | 206 | 219/67.1 | 34.2 | 61.3 | 0.49 % | 11.3 % | 8.42 % | 2.00 |
| Orchid Pharma Ltd | 5,775 Cr. | 966 | 1,144/471 | 320 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| FDC Ltd | 5,400 Cr. | 331 | 476/313 | 17.5 | 153 | 1.51 % | 15.4 % | 11.2 % | 1.00 |
| Gujarat Themis Biosyn Ltd | 4,842 Cr. | 372 | 479/225 | 99.4 | 26.4 | 0.17 % | 18.1 % | 17.4 % | 1.00 |
| RPG Life Sciences Ltd | 4,780 Cr. | 2,896 | 3,130/1,731 | 41.0 | 366 | 0.83 % | 25.7 % | 19.3 % | 8.00 |
| SMS Pharmaceuticals Ltd | 4,472 Cr. | 478 | 494/262 | 49.4 | 85.9 | 0.08 % | 12.9 % | 11.9 % | 1.00 |
| Zota Health Care Ltd | 4,391 Cr. | 1,268 | 1,740/1,022 | 200 | 0.08 % | 8.47 % | 15.0 % | 10.0 | |
| Gufic BioSciences Ltd | 4,211 Cr. | 420 | 468/268 | 57.3 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| Aarti Drugs Limited | 3,778 Cr. | 415 | 534/319 | 21.8 | 154 | 0.48 % | 11.7 % | 12.7 % | 10.0 |
| Kwality Pharmaceuticals Ltd | 3,773 Cr. | 3,644 | 3,949/829 | 46.2 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Unichem Laboratories Ltd | 3,767 Cr. | 535 | 687/278 | 30.8 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Ind-Swift Laboratories Ltd | 3,354 Cr. | 386 | 425/87.0 | 51.5 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Solara Active Pharma Sciences Ltd | 3,280 Cr. | 677 | 774/422 | 768 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Advanced Enzyme Technologies Ltd | 3,049 Cr. | 272 | 420/252 | 19.3 | 146 | 1.96 % | 14.0 % | 10.2 % | 2.00 |
| Aurobindo Pharma Ltd | 96,479 Cr. | 1,677 | 1,740/1,066 | 25.5 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Hikal Ltd | 2,644 Cr. | 214 | 261/146 | 62.4 | 97.2 | 0.28 % | 3.50 % | 2.21 % | 2.00 |
| Venus Remedies Ltd | 2,402 Cr. | 1,797 | 2,044/432 | 20.7 | 497 | 0.56 % | 20.7 % | 15.6 % | 10.0 |
| Dishman Carbogen Amcis Ltd | 2,369 Cr. | 152 | 307/128 | 131 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Indoco Remedies Ltd | 2,278 Cr. | 247 | 317/162 | 102 | 0.08 % | 0.96 % | 9.36 % | 2.00 | |
| Syncom Formulations (India) Ltd | 2,252 Cr. | 24.0 | 27.5/10.2 | 26.5 | 4.39 | 0.42 % | 24.8 % | 17.6 % | 1.00 |
| Fredun Pharmaceuticals Ltd | 2,241 Cr. | 1,355 | 1,600/454 | 50.4 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Beta Drugs Ltd | 2,222 Cr. | 2,004 | 2,808/990 | 48.7 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Panacea Biotec Ltd | 2,152 Cr. | 350 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Hester Biosciences Ltd | 1,780 Cr. | 2,106 | 2,684/1,239 | 33.5 | 423 | 0.52 % | 15.2 % | 15.9 % | 10.0 |
| Fermenta Biotech Ltd | 1,628 Cr. | 553 | 580/249 | 29.8 | 138 | 0.68 % | 20.6 % | 16.4 % | 5.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,515 Cr. | 229 | 265/155 | 32.2 | 41.2 | 1.74 % | 22.7 % | 17.3 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,496 Cr. | 518 | 760/476 | 24.0 | 128 | 0.95 % | 24.8 % | 18.4 % | 1.00 |
| TTK Healthcare Ltd | 1,431 Cr. | 1,013 | 1,250/735 | 18.7 | 789 | 0.99 % | 8.04 % | 6.30 % | 10.0 |
| Kopran Ltd | 1,298 Cr. | 269 | 296/107 | 51.9 | 110 | 1.12 % | 6.65 % | 4.91 % | 10.0 |
| Lincoln Pharmaceuticals Ltd | 1,136 Cr. | 567 | 770/440 | 11.8 | 378 | 0.32 % | 16.3 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 1,042 Cr. | 113 | 147/65.0 | 43.3 | 0.44 % | 2.74 % | 0.41 % | 1.00 | |
| Bafna Pharmaceuticals Ltd | 899 Cr. | 386 | 393/94.8 | 115 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Anuh Pharma Ltd | 860 Cr. | 85.8 | 99.5/66.7 | 19.5 | 35.1 | 1.75 % | 14.9 % | 10.7 % | 5.00 |
| Kilitch Drugs (India) Ltd | 826 Cr. | 234 | 248/117 | 27.5 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Wanbury Ltd | 692 Cr. | 198 | 360/162 | 16.1 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Albert David Ltd | 481 Cr. | 836 | 932/580 | 21.3 | 686 | 0.60 % | 0.82 % | 0.44 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 331 Cr. | 104 | 108/50.3 | 79.4 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| BDH Industries Ltd | 278 Cr. | 482 | 610/340 | 23.7 | 134 | 1.04 % | 20.5 % | 14.8 % | 10.0 |
| Lyka Labs Ltd | 277 Cr. | 77.5 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| Gennex Laboratories Ltd | 241 Cr. | 9.93 | 17.2/7.05 | 12.8 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Everest Organics Ltd | 219 Cr. | 220 | 536/197 | 41.7 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Nectar Lifescience Ltd | 202 Cr. | 10.5 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Coral Laboratories Ltd | 196 Cr. | 549 | 679/360 | 10.3 | 585 | 0.36 % | 11.0 % | 7.79 % | 10.0 |
| Bal Pharma Ltd | 170 Cr. | 107 | 125/59.7 | 23.6 | 51.6 | 1.12 % | 9.69 % | 7.87 % | 10.0 |
| Brooks Laboratories Ltd | 159 Cr. | 54.2 | 138/36.3 | 12.0 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Par Drugs & Chemicals Ltd | 155 Cr. | 126 | 180/78.0 | 10.7 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Auro Laboratories Ltd | 152 Cr. | 244 | 317/159 | 31.7 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Achyut Healthcare Ltd | 143 Cr. | 5.91 | 10.0/4.70 | 446 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Lactose (India) Ltd | 135 Cr. | 107 | 136/76.0 | 19.4 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 135 Cr. | 64.0 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 134 Cr. | 9.14 | 14.3/1.96 | 44.6 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Godavari Drugs Ltd | 127 Cr. | 116 | 135/69.7 | 32.6 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Alpa Laboratories Ltd | 123 Cr. | 59.0 | 99.8/46.0 | 28.1 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Vaishali Pharma Ltd | 109 Cr. | 8.38 | 11.9/4.75 | 25.8 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Pharmaids Pharmaceuticals Ltd | 106 Cr. | 30.2 | 60.0/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Concord Drugs Ltd | 99.7 Cr. | 75.7 | 92.5/61.0 | 48.9 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Denis Chem Lab Ltd | 93.5 Cr. | 67.4 | 97.4/56.1 | 11.7 | 66.0 | 3.71 % | 14.0 % | 9.52 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Fervent Synergies Ltd | 73.3 Cr. | 14.7 | 26.0/13.0 | 20.1 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Cian Healthcare Ltd | 61.2 Cr. | 24.5 | 24.5/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| ANG Lifesciences India Ltd | 52.5 Cr. | 40.2 | 49.7/17.6 | 47.6 | 0.00 % | 1.14 % | 7.38 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 47.7 Cr. | 29.6 | 46.8/25.6 | 99.4 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| Vivimed Labs Ltd | 47.3 Cr. | 5.71 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Mangalam Drugs and Organics Ltd | 46.4 Cr. | 29.2 | 74.0/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Bacil Pharma Ltd | 39.2 Cr. | 27.3 | 61.8/10.6 | 60.2 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.53/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Chandra Bhagat Pharma Ltd | 37.3 Cr. | 49.4 | 53.0/29.7 | 12.2 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Bharat Immunological & Biological Corporation Ltd | 35.3 Cr. | 8.18 | 22.6/8.16 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Gujarat Terce Laboratories Ltd | 26.9 Cr. | 34.5 | 59.8/29.0 | 12.1 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Colinz Laboratories Ltd | 18.5 Cr. | 73.5 | 87.9/36.1 | 37.0 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Checkpoint Trends Ltd | 17.4 Cr. | 31.9 | 144/28.4 | 14.2 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Beryl Drugs Ltd | 12.8 Cr. | 25.3 | 27.6/15.9 | 20.7 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 11.8 Cr. | 79.0 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Dipna Pharmachem Ltd | 10.9 Cr. | 4.15 | 25.0/3.90 | 4.15 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Adline Chem Lab Ltd | 8.80 Cr. | 15.0 | 17.1/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Brawn Biotech Ltd | 7.38 Cr. | 24.6 | 24.7/17.7 | 8.68 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Decipher Labs Ltd | 6.06 Cr. | 6.00 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.15 Cr. | 0.78 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Evoq Remedies Ltd | 3.78 Cr. | 1.52 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| Dr Reddys Laboratories Ltd | 1,00,922 Cr. | 1,203 | 1,415/1,080 | 31.3 | 454 | 0.67 % | 13.0 % | 11.2 % | 1.00 |
| Mankind Pharma Ltd | 1,04,707 Cr. | 2,535 | 2,642/1,910 | 46.3 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Laurus Labs Ltd | 1,06,249 Cr. | 1,971 | 2,055/843 | 122 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Cipla Ltd | 1,07,663 Cr. | 1,336 | 1,673/1,166 | 30.1 | 426 | 0.97 % | 15.5 % | 11.6 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,81,333 Cr. | 4,767 | 5,250/3,480 | 81.3 | 248 | 0.80 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,506.20 Cr | 1,247.43 | 54.42 | 211.24 | 0.39% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Ipca Laboratories Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Ipca Laboratories Ltd analysis · Explore all Pharmaceuticals stocks